Results showed that reduced expressions of MSH6/2 and PD-L1 mRNA in SCAs partially account for the molecular mechanism causing proliferative and invasive characteristics as the reduction of MSH6/2 could decrease the rate of apoptosis and promote cell-cycle progression, and the reduction of PD-L1 could provide a relatively functional tumor immunity. The gene discussed is CD274; the disease is neoplasm.